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ABSTRACT
Substance abuse is a global problem that has contributed to a variety of societal,
financial, health, and familial strains. An increasing prevalence of illicit drug,
prescription opioids, and alcohol abuse has created a need for re-evaluation of recovery
and relapse treatments. This literature review examines the efficacy of meditation-based
treatments for relapse prevention in persons recovering from Substance Use Disorders
(SUDs). A comparative analysis of Mindfulness Based Relapse Programs (MBRP), an
adapted MBRP-W program, and a Transcendental Meditation (TM) intervention was
used to examine the success of meditation-based interventions. Research supports
improvements associated with the meditation-based interventions including significant
reductions in substance use, craving, stress, and negative affect. Meditation-based
therapy may provide the emotional self-regulation and decreased impulsivity required
for long-term abstinence from substance use. Consistent meditative practice was
associated with greater improvements. Altering current meditation-based therapy
treatment programs to encourage adherence and participation may increase success.
Additional research is needed to evaluate long-term relapse prevention potential.
Research incorporating meditation-based supportive therapies that promote well-being,
emotion regulation, and stress relief are important for the future of successful SUD
treatment.
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INTRODUCTION
Substance abuse is prevalent globally and has contributed to a variety of societal,
financial, health, and familial strains. An increasing prevalence of illicit drug,
prescription opioid, and alcohol abuse has created a need for re-evaluation of recovery
and relapse treatments. Research supports that meditation-based therapy can
potentially offer a tool for self-regulation of emotions and impulsivity, and may provide
an adjunctive therapy to promote recovery program adherence.

The American Drug Crisis
Substance abuse has ramifications that can affect work or school, promote
financial hardship, contribute to domestic and child violence, initiate arrests and prison
time, and create serious health problems including death (National Institute on Drug
Abuse, n.d.). Illicit drug use statistics continue to rise. In 2017, more than 72,000
Americans died from drug overdose—a statistic that has doubled in the past decade. The
most contributory substances were natural and synthetic opioids, and stimulants
including cocaine and methamphetamine (National Institute on Drug Abuse, 2018).
Statistics from 2015 indicate that 15.1 million adults, about 6.2 percent of the
population, had Alcohol Use Disorder (AUD) with an estimated 88,000 dying annually
from alcohol-related deaths. Based on this data, alcohol use is the third leading cause of
death in the United States (US) (National Institute on Alcohol Abuse and Alcoholism,
2018).
The significant costs to society are evidenced by drug-related crime statistics.
Approximately 18 percent of inmates state that they committed their current offense to
7

obtain money for drugs (Office of Justice Programs, 2018). According to the 2017
National Crime Victimization Survey, 26 percent of victims aged 12 and older claimed
that they believed the offender was under the influence of drugs or alcohol (Office of
Justice Programs, 2018). About 72 percent of state prisoners with mental health issues
and 56 percent of those without mental health issues reported that they were dependent
on or abused alcohol and drugs.
Substance Use Disorders (SUD) can have a significant toll on familial and partner
relationships. Each family member can be affected and at risk for having “unmet
developmental needs, impaired attachment, economic hardship, legal problems,
emotional distress and subjection to violence” (Lander, Howsare, & Byrne, 2013, p. 194).
Maternal opioid use and Neonatal Abstinence Syndrome (NAS) incidences have risen
“300 percent from 1.5 per 1,000 hospital births in 1999 to 6.0 per 1,000 hospital births
in 2013” (Ko et al., 2016, p. 799). This syndrome is most often attributed to in utero
opioid exposure and is manifested by central nervous system irritability, autonomic
over-reactivity, and gastrointestinal tract dysfunction.The Centers for Disease Control
and Prevention (CDC) found that 1 in 10 pregnant women had consumed alcohol and 1
in 33 reported binge drinking in the past month (Centers for Disease Control and
Prevention [CDC], 2018). Alcohol consumption during pregnancy causes Fetal Alcohol
Spectrum Disorders (FASDs) exhibited by physical deformities and underdevelopment.
FASDs are often manifested by a small head size, short stature and low body weight,
organ or bone problems, and cognitive impairments including hyperactivity, poor
attention and memory, learning and language delays, intellectual disabilities, and
possible fetal death (CDC, 2018).
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Children who have a parent with a SUD are more likely to have a lower
socioeconomic status and increased difficulties in academic and social settings, in
addition to impaired family functioning (Peleg-Oren & Teichman, 2006). Based on data
from 2009 to 2014 from The National Surveys on Drug Use and Health, 1 in 8 children
aged 17 and under lived with at least one parent with a SUD, including 1 in 10 with AUD
and 1 in 35 who had a parent that used illicit drugs (Lipari & Struther, 2017). These
children are more likely to demonstrate higher rates of mental and behavioral disorders
(Peleg-Oren & Teichman, 2006). In the absence of a positive extended support system,
many of these children grow up to have SUDs themselves (Biederman, Faraone,
Monuteaux, & Feighner, 2000; Peleg-Oren & Teichman, 2006).

Defining Substance Use Disorder
SUD is a general diagnosis that covers a range of disorders involving the abuse of
at least one out of the 10 classes of potentially addictive drugs. These substances include
alcohol, caffeine, cannabis, hallucinogens, inhalants, opioids, stimulants (including
amphetamine derivatives and cocaine), tobacco, “other” substances, and sedatives,
hypnotics, and anxiolytics (American Psychiatric Association, 2013). Diagnosis of a SUD
requires that the clinician specifies the substance being used (e.g. alcohol use disorder,
cocaine use disorder, heroin use disorder) or that all drugs are identified if the
individual is a polysubstance abuser. Important symptomatic criteria for diagnosis
includes impaired control and a persistent inability to cut down or regulate use,
spending large amounts of time obtaining and using the drug, and experiencing craving,
social impairment, and risky use that threatens health (American Psychiatric
Association, 2013; Lipari & Struther, 2017). Although each drug class has a different
9

pharmacological approach, they each activate the same brain reward system that is
usually involved in the reinforcement of behaviors and the production of memories. This
intense activation and chase for a “high” often leads to neglect in normal activities and
most often manifests in individuals with reduced self-control (American Psychiatric
Association, 2013). This cluster of cognitive, behavioral, and physiological symptoms
indicates that an individual will continue to use substances despite the ramifications of
significant substance-related problems. The prevalence of polysubstance abuse has
further contributed to higher rates of overdoses and mortalities (European Monitoring
Centre for Drugs and Drug Addiction, 2002).

Trauma, Impulsivity, and Emotional Dysregulation as Personality
Traits in Person’s with SUDs
The use of illicit drugs, alcohol, or prescription medications with addictive
properties does not definitively mediate the development of a SUD. Research has shown
strong correlations between trauma, including adverse childhood experiences of neglect
and abuse and adult acquired Post-Traumatic Stress Disorder (PTSD), in the
development of psychiatric traits and SUDs (Mergler et al., 2018). Exposure to sexual
and physical abuse in childhood significantly contributes to the development of mental
and emotional disorders such as depression, anxiety disorders, conduct/antisocial
personality disorder, substance dependence, and suicide attempts in adulthood
(Fergusson, Boden, & Horwood, 2008). There is an especially strong relationship
between the number of childhood adversities and consequential self-destructive
behavior and substance abuse (Dube, Anda, Felitti, Edwards, & Croft, 2002;
Maremmami et al., 2018). The self-medication hypothesis of addictive disorders states
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that PTSD patients may use substances to relieve painful symptoms, contributing to the
development of SUDs (Khantzian, 1985). Exposure to interpersonal trauma, especially
during developmentally sensitive time periods, contributes to an altered response in
emotional processing (Langevin, Hebert, & Cossette, 2015).
Emotional (affect) dysregulation is a personality trait that reflects problems with
under-regulation of heightened affect states or maladaptive overregulation of affect
leading to detachment. Having a limited ability for effective strategies to reduce intense
affect states leads to problems with impulse control and goal-directed behavior (PatHorenczyk et al., 2015; Van Dijke, Hopman, & Ford, 2017). It is characterized by intense
emotions, low distress tolerance, experiential avoidance, and a lack of control or
strategies to effectively manage emotions (Eftekhar, Zoellner, & Vigil in 2009 and
Moore, Zoellner, & Mollenholt in 2008 as cited in Price et al., 2018). Growing research
is showing a link between emotion dysregulation and substance use (Kelly & Bardo,
2016). This is a trait that accompanies many mental health disorders and is a key feature
of borderline personality types (Schulze, Schmahl, & Niedtfeld, 2016).
There is a significant relationship between mental health disorders and the
presence of a SUD. Multiple studies have documented high but variable rates of DSM
personality disorders (PD) in clinical samples of substance abusers (Rounsaville et al.,
1998). A strong comorbidity has been found between alcohol abuse, drug-dependence,
and depression that was supported by previous clinical observations (Swendsen &
Merikangas, 2000). In an evaluation of alcoholic outpatients, 80 percent had either a
coexistent axis I or II disorder (Nurnberg, Rifkin, & Doddi, 1993). Another study found
that 57 percent of patients with substance use disorders met criteria for at least one
comorbid axis II disorder with antisocial PD and borderline PD being the most
11

predominant (Rounsaville et al. 1998). Both conditions manifest in adolescence and
reflect difficulties with emotional regulation and impulsivity.
Certain personality traits in SUDs have been measured and can be considered
prevalent in this population. Research has shown that externalizing behaviors and
sensation seeking, especially in later adolescence and young adulthood, may contribute
to the pursuit of risky behaviors (McCabe, Louie, & King, 2015). One characteristic that
is a frequent predictor of risk behavior is trait impulse control, also understood to be an
inability for premeditation. Early studies have related poor impulse control to
externalizing and conduct problems (Whiteside & Lynam, 2009). Other studies found
links between impulsivity, alcohol problems and drug use (Coskunpinar et al., 2013;
Stautz & Cooper, 2013; Verdejo-Garcia, Lawrence, & Clark, 2008). McCabe, Louie, and
King’s (2015) study concluded high sensation seeking along with increased impulsivity
were characteristics that significantly contributed to the highest rates of drinking and
drug consequences.

Conventional Treatments
Following detoxification, common treatments for SUDs include individual and
group counseling, inpatient and residential treatment, partial hospital programs,
medication, recovery support services, 12-Step fellowships, and peer support systems.
Counseling treatments include cognitive behavioral therapy (CBT) to build skills that
promote abstinence, contingency management to provide incentive and positive
reinforcement, motivational enhancement therapy to build motivation and
commitment, and 12-step facilitation therapy to promote cognitive restructuring (Desert
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Hope, n.d.; McHugh, Hearon, & Otto, 2011; Substance Abuse and Mental Health
Services Administration [SAMHSA], 2018).
There are diverging opinions in literature about the effectiveness of Alcoholics
Anonymous (AA) and Narcotics Anonymous (NA). Data on program adherence is
difficult to quantify given the nature of anonymity and the lack of accurate data records
collected by each program, however attrition is generally high with 91 percent of AA and
85 percent of NA members stopping attendance for a month or longer (Krentzman et al.,
2010). Reasons for leaving include using drugs and alcohol and not feeling ready to stop
or wanting to recover independently. These reasons reflect the inefficacy of both
programs in enhancing motivation and confidence to continue with recovery.

Defining Meditation
In the past three decades there has been a growth in the interest and use of
meditation by western therapeutic programs. Buddhist practices may be considered the
standard for understanding the effects of meditation, which can easily be interpreted
into secular thought and have been widely studied by neuroscientists and psychologists
in the last few decades (Ekman, Davidson, Richard, & Wallace, 2005). Buddhists and
psychologists similarly believe that emotions strongly influence people’s thoughts,
words, and actions. Buddhists maintain that happiness is attained through sustained
training in attention, emotional balance, and mindfulness, to help one distinguish
between how things appear to the senses and the self-projection of superimpositions on
them. This training results in a shift in fleeting emotions, and eventually leads to a
change in mood and temperament (Ekman et al., 2005). Certain mental states such as
craving, hatred, and the delusion of an identity as concrete, are considered afflictive
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regardless of degree or context. Craving is based on an unrealistic, reified distinction
between the self and others or objects, creating an unbalance in the mind that gives rise
to anxiety, misery, fear, and anger (Ekman et al., 2005).
Neuroscience is showing that dopamine release from the nucleus accumbens is
common to states of craving regardless if it is pharmacologically or activity induced and
is not associated with pleasure in the long run. In this sense, meditation practices offer a
chance for individuals to reflect on their own internal experiences and can offer a
therapy for anyone seeking to improve the quality of their lives (Ekman et al., 2005).
With the increasing western interest in meditative practice, research has
attempted to classify the different types of meditation according to their foci. The two
main types that can be distinguished are focused attention (FAM) and open monitoring
(OMM). FAM involves maintaining a sustained selective attention on a chosen concept
or object, such as breathing, physical sensation, or a visual image, whilst avoiding mind
wandering (Lee, Kulubya, Goldin, Goodzari, & Girgis, 2018). FAM is associated with
intentional activity within the attentional network and induces a narrow attentional
focus due to its highly concentrative nature (Fujin, Ueda, Mizuhara, Saiki, & Normura,
2018; Lippelt, Hommel, & Colzato, 2014). OMM involves an acceptance of internal and
external cues while maintaining a non-judgmental awareness (Fujin et al., 2018). This
includes the increasingly well-known concept of mindfulness and its associated
therapies, which are defined by leading researcher John Kabat-Zinn as “the awareness
that emerges through paying attention on purpose, in the present moment, and
nonjudgmentally to the unfolding of experience moment by moment” (Kabat-Zinn,
2003, p. 145). OMM also includes Vipassana, which influenced the core techniques of
mindfulness-based stress reduction therapies (Samuel, 2015). In contrast to FAM, OMM
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induces a broader attentional focus and allows practitioners to develop a more acute and
less emotionally reactive awareness of their experiences (Fujin et al., 2018; Lippelt et al.,
2014). There is some overlap between the two types, namely that in OMM there may
initially be an object focus, often the breath, with the goal of gradually shifting focus into
the broader monitoring of arising sensations and thoughts, and then further into the
monitoring of awareness itself (Lee et al., 2018).

Structural and Functional Changes through Meditative Practice
Several methods that measure brain activity and function have been used in
comparative studies to evaluate the effects of meditative practices for influencing
structural and functional changes in neuroanatomy. In comparing scalp
electroencephalography (EEG) wave readings of experienced Zazen meditators (OMM)
during non-meditative and meditative states there were significant changes in the
Default Mode Network (DMN) during meditation. Increased alpha activity was found
primarily in the right hemisphere including areas associated with emotional processing,
self-reference based on momentary experience, response inhibition, increased executive
control, and increased momentary proprioception (Faber et al., 2014). Aftanas and
Golosheykin (2005) compared the EEG response of experienced Sahaja Yoga mediators
(OMM) against controls during rest periods, with alternating periods of the eyes
opening and closing, and while watching an aversive movie clip to promote a negative
emotional response. The meditators showed less tonic arousal and more internalized
attention with less attentional involvement while viewing the neutral movie clips.
Additionally, whilst both groups showed significant alpha desynchronization, reflecting
an arousing nature of emotional induction, the control group showed significantly
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higher levels and additional gamma synchronization, which reflects a “focused arousal”
state, suggesting a heavier emotional workload on the control group compared to the
meditators (Aftanas & Golosheykin, 2005; Sheer, 1989). Data from these studies
supports that individuals who meditate regularly have capabilities for moderating the
intensity of their negative emotional arousal.
Diffusion Tensor Imaging (DTI) is an imagery modality that can be used to
quantify white matter bundles in the brain to compute the fractional anisotrophy (FA),
indicating patterns of brain conductivity. A higher FA reflects enhanced connectivity.
Luders, Clark, Narr, and Toga (2011) compared a variety of long term mediators against
controls and found significantly higher FA levels in areas that may contribute to a
meditator’s ability to cultivate positive emotions, retain emotional stability, and engage
in mindful behavior. Similarly, Newberg et al. (2010) used Single Photon Emission
Computed Tomography (SPECT) imaging to measure baseline cerebral blood flow in a
group of long-term meditators against controls, and found significantly higher ratios in
areas that have roles in emotion regulation. These areas showed more permanent
differences compared to controls.
Gray matter density provides another useful measurement, which is assumed to
increase after repeated activation. Magnetic Resonance Imaging (MRI) data was taken
from meditation-naïve participants suffering from chronic stress before and after
completing an intensive 8-week mindfulness training. Researchers found significant
increases in gray matter concentrations with significant group by time interactions in
areas that suggest an improved function in regulating emotional responses and possibly
signify an increased self-reflection by applying emotional context to self-reference
(Hölzel et al., 2011). Research supports that meditators have an enhanced control over
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emotional processing and responses, which has been quantitatively measured through a
variety of modalities.

Meditation in Clinical Therapy
Meditative practice found scientific roots in the 20th century when researchers
studied Buddhist practitioners in hopes of understanding a pervasive perception of
improved mental wellbeing in this population. In the late 1970s social psychologist Dr.
Ellen Langer began her strictly secular research on the illusion of control, mindful aging,
stress, and decision-making, and established evidence-based therapies using everyday
mindfulness without meditation through developing The Langer Mindfulness Institute
(Langer, 2009). In 1979 Dr. Jon Kabat-Zinn opened the Center for Mindfulness in
Medicine, Health Care, and Society at the University of Massachusetts Medical School,
and created the Mindfulness-Based Stress Reduction (MBSR) program by adapting
ancient traditions with clinical evidence to treat a wide variety of issues in western
medicine (Tippet, 2012). Kabat-Zinn applied teachings of Vipassana meditators to
create an OMM-incorporated therapy. The MBSR program has a patient-centered
education approach and its primary goals are to teach people how to take better care of
themselves and facilitate adaptation to life’s stressors (Kabat-Zinn, 2014). The program
includes 8-weekly classes that are 2.5-3.5 hours long; with formal mindfulness training
in a body scan meditation, supine Gentle Hatha Yoga, mindfulness of breath, body,
thoughts, and emotions, and an awareness walking meditation. It also includes
instruction for everyday mindfulness, around an hour of daily home assignments for 6days a week, individual and group reflection meetings, an all-day silent retreat, and
introduction and exit interviews (Kabat-Zinn, 2014). Studies have found therapeutic
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uses for MBSR in treating anxiety, depression, substance abuse, eating disorders, and
fibromyalgia pain (Bowen et al., 2006; Grossman, Tiefenthaler-Gilmer, Raysz, & Kesper,
2007; Hofmann, Sawyer, Witt, & Oh, 2010; O’Reilly, Cook, Spruijt-Metz, & Black, 2014).
In 1992, the Dalai Lama invited neuroscientist Dr. Richard Davidson to use
modern tools in neuroscience to study how long-term meditation had changed the
brains of Indian monks. Through his research, Davidson redefined the concept of
neuroplasticity, which is the ability of the brain to produce measurable change.
Davidson discovered differences in gamma oscillations of electrical brain activity
between conventional persons and long-term meditators who showed continuous
readings for several minutes at very high amplitudes (Tippet, 2012). Davidson reports in
Tippet (2012) that the quality of clarity in the meditator was highly correlated with the
presence of the gamma oscillations. In 2008, Davidson founded the Center for
Investigating Healthy Minds for treating neurological disorders such as AttentionDeficit/Hyperactivity Disorder (ADHD), anxiety, affective disorders, PTSD, and autism
(Tippet, 2012).
Mindfulness practices are increasingly being adapted into new therapeutic
programs. Mindfulness-Based Cognitive Therapy (MBCT) combines mindfulness
meditation with cognitive therapy to break the cycle of recurrent depression and has
clinical support for symptom reduction (University of Massachusetts Medical School,
2017). This 8-week program helps participants become aware of how conditioned
patterns of mind and mood can trigger depression relapse and sustain current
depressive symptoms. Being aware of the signs of relapse allows for early intervention
and continued practice can reduce the need for medication (University of Massachusetts
Medical School, 2017).
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Two therapies that are offered for relapse prevention are the Mindfulness-Based
Relapse Prevention (MBRP) and the Mindfulness-Based Therapeutic Community
programs (MBTC). MBRP is a 5-day course that incorporates interventions from Dr.
Alan Marlatt’s Relapse Prevention Therapy (RP), MBSR, and MBCT (UCSD Center for
Mindfulness, n.d.). It is designed to prevent relapse for SUDs after undergoing inpatient
treatment or intensive outpatient treatment. This program helps participants to
recognize and stay with physical, emotional, and cognitive discomfort, and to “cultivate
heightened awareness of internal and external triggers while promoting healthy lifestyle
modifications that support recovery” (UCSD Center for Mindfulness, n.d., para. 2). Like
12-step programs, this program promotes acceptance, letting go of personal control, and
the use of meditation (prayer) practices. Differences from AA and NA programs include
the exclusion of labels like “addict”, “alcoholic” or “diseased”, an admission of
powerlessness, and the use of a Higher Power for motivation (Stout, n.d.). Also
important in the MBRP program is that it offers abstinence for individuals without
insisting on it, which is beneficial in reducing harm from problem behaviors and
emphasizing moderation approaches. Overall, this program emphasizes the internal
power of individuals using CBT, without emphasis on the “failures” of relapse (Stout,
n.d.).
Therapeutic communities (TC) have long been recognized as a method to treat
SUDs by supporting social learning contributing to a change in worldview and selfimage (De Leon, 2010). Attrition rates can be as high as 50 percent with the greatest
dropout rates occurring in the first 30-60 days. Stress is considered a contributory
factor to attrition, so MBTC programs have adapted MBSR for the TC aiming to reduce
stress and increase retention (Marcus et al., 2009).
19

PURPOSE
Statistical trends indicate an increasing prevalence of drug and alcohol abuse,
which can have several concurrent societal, financial, and health consequences.
Traditional recovery programs have high rates of attrition and relapse, signifying a need
for alternative or additional treatment methods. Meditation research demonstrates a
potential for enhanced emotional processing and increased impulsivity and craving
modulation. This literature review explored the feasibility and effectiveness of
mediation-based treatments, which may provide an alternative or adjunctive therapy for
relapse prevention.
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METHODOLOGY
Databases including CINAHL and CINAHL Plus with Full Text, Cochrane Central
Register of Controlled Trials, MEDLINE, PsycARTICLES and psycINFO were searched
using key words and limiters. Key words included “substance abuse”, “addiction”,
“alcohol abuse”, “narcotic abuse”, “substance use disorder”, or “drug dependence” and
“relapse”, “recurrence”, or “regression”, and “meditation”, “mindfulness”, “mindfulness
based stress reduction”, “mindfulness based relapse prevention”, or “mindfulness based
therapeutic community”.
Studies measuring relapse prevention efficacy after a non-movement based
meditation therapy that met inclusion criteria were evaluated. Scholarly, peer reviewed
journals with publications from 2008 to 2018 were included. Exclusion criteria
included movement-based meditation such as yoga and qigong, qualitative studies, nonEnglish articles, secondary analyses, systemic reviews, short communications, study
protocols, and editorials. Neurofeedback, pharmacological, and faith-based treatments
were also excluded, to decrease the influence of external factors on meditative practice
outcomes. Studies comprising of group sizes less than 20, with an absent control group,
or employing a weak design were removed from the final analysis.
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FINDINGS
Seven articles that met the inclusion criteria are included in this review. All of the
studies used experimental designs. Five studies evaluated all SUDs including alcohol,
illicit drugs, and polysubstance. One study addressed stimulant dependence and
another examined AUDs. There were a variety of SUD interventions tested. Five studies
evaluated the efficacy of MBRP, one study used an adapted program Moment-byMoment in Women’s Recovery: A Mindfulness-Based Approach to Relapse Prevention
(MBRP-W), and another implemented a 14-week Transcendental Meditation (TM)
intervention. All research was conducted in the United States and approved by an
institutional review board (IRB). Financial incentives were used to recruit participants
and reduce attrition.
The first randomized controlled trial (RCT) to evaluate an MBRP intervention
was conducted by Bowen et al. (2009) with the purpose of discovering the feasibility and
initial efficacy of an MBRP intervention compared to treatment as usual (TAU) by
assessing substance use outcomes, craving, mindfulness, and acceptance. This trial
assessed a sample with a range of SUDs: alcohol (45.2%), cocaine/crack (36.2%),
methamphetamines (13.7%), heroin and other opiates (7.1%), marijuana (5.4%), others
(1.9%), and polysubstance (19.1%). The intervention consisted of 2-hour weekly group
meetings over 8-weeks facilitated by two therapists with intensive MBRP training.
Sessions included 20-30 minutes of guided meditation with experiential exercises,
discussion of the mindfulness role in relapse prevention, homework, daily exercises, and
guided meditation CDs. The TAU group met once or twice weekly in 1.5-hour sessions
for a 12-step supported process-oriented program that used relapse prevention skills
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according to the disease model of addiction (Bowen et al., 2009). There were 168
participants in the sample between 18 and 70 years of age that were 63.7 percent male,
51.8 percent Caucasian, and 28.6 percent African American. Legally mandated and
homeless participants were included. There were four assessment points over the 4month study period. There was 61 percent retention post-intervention, 57 percent at 2months, and 73 percent at 4-months.
Several self-report measures were used. The Timeline Followback (TLFB)
addressed the previous 60 days of substance use, the Penn Alcohol Craving Scale
(PACS) was adapted to include drug craving, the Short Inventory of Problems (SIP-AD)
assessed impulse control, social responsibility, and substance use consequences, the
Acceptance and Action Questionnaire (AAQ) which assessed acceptance versus
avoidance and control of negative private experiences, and the Five Factor Mindfulness
Questionnaire (FFMQ). Meditation practice was recorded weekly and a feedback
questionnaire evaluated course satisfaction (Bowen et al., 2009).
Bowen et al. (2009) found that alcohol or drug (AOD) use decreased to greater
extent among MBRP participants compared to TAU (p <.001). There was a curvilinear
effect of MBRP treatment where treatment gains decayed by 4-months postintervention and a “curvilinear decrease in the experience of substance use problems
over time. Overall there were no significant treatment interactions or main effects of
treatment on substance use problems (p > .68)” (Bowen et al., 2009, p. 301). Over time,
craving decreased to a greater extent among MBRP participants (p < .001), however the
magnitude of decreases in craving plateaued over the 4-month post-intervention period.
The Acceptance (AAQ) model was statistically significant (p = .02) so that over time
acceptance increased more among MBRP participants. These increases “plateaued over
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4-months post intervention. The acting with awareness (FFMG-ACT) model was
marginally significant (p = .07) suggesting that acting with awareness increased to
greater extent in MBRP versus TAU participants for whom it decreased. At four months
post-intervention increases in acting with awareness among MBRP participants
plateaued” (Bowen et al., 2009, p. 302). Overall, participants rated MBRP course as
highly important with a high likelihood of continuing formal and informal practices (p <
.001).
A similar RCT by Bowen et al. (2014) assessed the relative efficacy of MBRP, RP,
and TAU on 12-month SUD outcomes from October 2009 to July 2012. Two hundred
and eighty six individuals between 18 to 70 years of age were recruited. The majority
were male (71.5%), Caucasian (57.9%), and had completed initial intensive inpatient or
outpatient care from a 2-site private, non-profit chemical dependency treatment agency.
The type of drug and alcohol use among participants was not specified. There were 103
participants randomized to MBRP, 88 to RP, and 95 to TAU. The MBRP group
comprised of 6-8 members per group and followed the same structure as the study by
Bowen et al. in 2009 plus tracking sheets to monitor daily craving and mood. The RP
group matched MBRP in time, format, group size, location at the agency site, and scope
of assigned homework. Objectives for discussion included the assessment of high-risk
situations, cognitive and behavioral coping skills, problem solving, goal setting, selfefficacy, and social support with daily monitoring of craving and mood. Both RP and
MBRP participants were removed from the primary aftercare groups of the agency and
returned following program completion. The TAU group maintained abstinence and was
primarily process-oriented, based on the AA/NA 12-step programs. Group meetings
were held once or twice weekly (n = 95) for 1.5-hours each (Bowen et al., 2014). Self24

report measures included the Addiction Severity Index (ASI) to track abstinence at the
baseline and end of treatment, the Severity of Dependence Scale (SDS) for reporting
symptoms of substance dependence, and the TLFB to account for the 30-day period
before the baseline and subsequent periods between assessments. In addition,
biophysical assessments using urinalysis drug and alcohol screening were obtained from
a subset of participants (n = 199) who were court mandated or otherwise identified for
testing by the agency.
Data was collected at four time points: baseline, 3-months post-intervention, 6months post-intervention, and 12-months post-intervention (Bowen et al., 2014).
Compared with TAU, MBRP and RP groups showed a 54 percent decreased risk of
relapse to drug use and a 59 percent decreased risk of relapse to heavy drinking.
Compared to RP, MBRP showed 21 percent increase in relapse risk to first drug use. The
groups did not significantly differ on time to first heavy drinking day. At the 3-month
follow-up there were no significant group differences on drug use days, any drug use,
heavy drinking days (4+ drinks for women, 5+ for men), or any heavy drinking days
between all groups (Bowen et al., 2014). At the 6-month follow-up the RP and MBRP
groups reported 31 percent fewer days of drinking compared with the TAU groups and
both MBRP and RP groups had significantly higher probabilities of abstaining from
drug use and heavy drinking compared to TAU. There were no significant differences
between MBRP and RP at this time point. The 12-month follow-up found that MBRP
participants reported 31 percent fewer drug use days and a significantly higher
probability of not engaging in heavy drinking (Bowen et al., 2014).
In a 2018 study by Davis et al. the effects of TAU plus MBRP were compared to
TAU plus additional 12-step meetings to evaluate perceived stress, craving, and
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substance use. Hypotheses stated that MBRP participants would have lower craving
during the treatment and in the post treatment phase and would have lower levels of
substance using days and perceived stress during post-treatment. Furthermore, it was
hypothesized that reductions in treatment-phase stress would mediate the association
between both MBRP assignment and post-treatment craving and between MBRP
assignment and post-treatment substance using days (Davis et al., 2018). Participants
were between 18-29 years old and were 65 percent male and 91 percent Caucasian who
had one or more parents with a SUD and were primarily unemployed illicit drug users.
Most had spent a large portion of time in jail or prison and 90 percent were
polysubstance abusers. The sample was recruited from a residential, public, non-profit
substance use treatment center that provided care to low-income patients with SUDs.
Seventy-nine participants were randomized to MBRP (n = 44) or TAU (n = 35). A rolling
group format was used to accommodate individuals as they entered the residential
facility, which was in contrast to the conventional 8-week cohort-based protocol. The
intervention was in addition to TAU. Sessions where led by two masters-degree level
clinicians with 200-hours of clinical training in mindfulness-based interventions. A
standardized “introduction” during each session covered the basics of mindfulness,
definitions, discussion of the triangle of awareness and the SOBER (Stop, Observe the
body, Breathe, Expand awareness, Respond mindfully) breathing space. A brief
meditation took all participants through the SOBER steps. The MBRP group met twice
weekly for 1.5-hour group sessions with 3-12 participants, which ensured course
completion during the average one-month residential stay. Each class included specific
themes, 20-30 minutes of homework daily using recorded guided meditation, and
written exercises. The control group using TAU only received Cognitive Behavioral
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Therapy (CBT) and 12-step approaches, with additional attendance to eight AA or NA
support groups to compensate for the “extra attention” received by the MBRP group
(Davis et al., 2018).
The follow-up post treatment phase was missing data from 17 percent (n = 14) of
participants. Ninety-five percent provided data at the 1-month follow-up, 81 percent
completed data collection at 3-months, and 75 percent completed assessments at 5months. Davis et al. (2018) found that at the end of treatment the MBRP participants
abstained from substance use immediately after treatment and maintained a flat
trajectory throughout the remainder of the study (p = .76). The TAU group tended to
show immediate increases in substance use (p < .001) that peaked & plateaued around
13 weeks after treatment. There were nearly statistically identical declines in levels of
craving during the treatment phase in both groups. These trajectories diverged
markedly upon leaving treatment (p < .001) with those in the MBRP group largely
maintaining low levels of craving throughout the remainder of the 28-week study period
(p = .29). The TAU group showed rather immediate and substantial increases in craving
levels before plateauing approximately 14-weeks post-treatment (p < .001)(Davis et al.,
2018). Only the MBRP group showed statistically significant (linear) improvements in
their stress levels during treatment phase (p = .18). The MBRP group showed
statistically less positive rates in perceived stress compared to the TAU group (p = .03)
upon leaving treatment and tended to maintain their lower, treatment-acquired stress
levels at 28-weeks post-treatment. Those in TAU group showed rather immediate
increases in stress levels that gradually slowed (p = .03) before plateauing around 17
weeks post-treatment. The data indicated a non-significant indirect effect for stress
between treatment assignment and craving, and a significant indirect effect for stress
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levels between treatment assignment and substance use. Post-treatment substance use
is expected to decrease by 0.45 SD for individuals assigned to MBRP via decreases in
perceived stress during treatment (Davis et al., 2018).
The feasibility, acceptability, and potential benefits for integrating the MBRP-W
program into SUD treatment for a culturally diverse, low income group of women was
evaluated by Amaro, Spear, Vallejo, Conron, and Black in 2014. This non-randomized,
non-controlled pilot trial examined the effects of substance use, perceived stress, and
trauma symptoms for 318 females aged 18-58. It was hypothesized that “MBRP-W
would be feasible and acceptable to culturally-diverse, low-income women in SUD
treatment and that it would be associated with decreases in addiction severity with
improvements in psychological functioning, particularly perceived stress and trauma
symptoms” (Amaro et al., 2014, p. 548-549). It was further hypothesized that
attendance in five or more sessions would provide meaningful outcomes. Multicultural
participants- Hispanic 45.3 percent, non-Hispanic Black 34.6 percent, and nonHispanic White 20.1 percent- with non-specified distributions of drug and alcohol use
disorders were recruited between April 2003 and December 2006. Participants had high
rates of unemployment (97.8%) and many were court mandated for treatment (45.6%).
The MBRP-W program was adapted from MBSR as a treatment for substance use
relapse prevention in women with a history of trauma exposure. The 1.5- to 2-hour
weekly sessions were delivered in groups of 8 to 12 participants in nine sessions. Groups
learnt meditation techniques, practiced gentle yoga, developed self-regulation strategies
such as using mindfulness to manage stress and difficult emotions, and participated in a
4-hour silent retreat during the seventh session. The program was reshaped from MBSR
to focus on the role of stress in relapse with effort to address a history of trauma and
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daily experiences of stress. The program’s goals were to refine self-regulatory skills,
increase relaxation and awareness, decrease stress and reactivity, become aware of
cravings with nonjudgmental observation, recognize early signs of relapse, and teach
skills to come back to the present moment. The program incorporated needs of
participants with trauma and mental health disorders and was sensitive to cultural
stigma that prevents Latina and African-American women from sharing experiences
with trauma and mental health. Groups were offered four to six times a year in English
and Spanish sequentially and closed to new participants after the second session. Selfreport measures were used to assess feasibility and acceptability with attendance sheets
to track the number of sessions participated in and a questionnaire to assess overall
satisfaction, attitude changes towards stress, and improvements in wellbeing. These
included four open-ended questions to address what participants liked best and least,
and what they would tell other women in recovery about their experience. Treatment
dosage was assessed using categorical variables to compare the effects of lower (1-4
sessions) and higher (5-9 sessions) doses of MBRP-W compared to those who attended
no sessions (Amaro et al., 2014). The alcohol and drug measures from the ASI were used
to evaluate the previous 30-days of substance use, including alcohol use to intoxication,
poly-drug use, and the frequency of problems related to substance use, the extent to
which the participant was troubled by substance-related problems, and the perceived
importance of treatment. The Perceived Stress Scale (PSS) was administered to assess
the response to stressors during the previous 30 days and an adapted version of the
Post-traumatic Diagnostic Symptom Scale (PDS) was used to assess the frequency of
intrusive thoughts, numbing, avoidances, hyper-arousal, vigilance, and other issues
experienced during the previous 30-days. All participants completed the PDS regardless
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of exposure to qualifying traumatic events as defined by the DSM-IV guide. Trauma
exposure was measured using the Life Stressor Checklist to assess lifetime and current
(past 6-months) exposure to traumatic or stressful events. Data collection occurred at
three time points during baseline interviews, 6-month follow-up, and 12-month followup (Amaro et al., 2014).
Amaro et al. (2014) found that all participants reported a history of exposure to
traumatic life events and 92 percent reported exposure in the previous 6 months prior to
enrolling. A higher percent of women from the Caucasian or other racial/ethnic
backgrounds group were found in the no MBRP-W and lower dosage groups. Women in
the high dosage group were more likely to be in residential treatment and court-ordered
treatment compared to the other groups. They were also more likely to be in SUD
treatment at six and 12-month follow-ups compared to the other groups. Almost twenty
percent attended one to four sessions, 35.8 percent attended five to nine sessions, and
44.3 percent did not attend any groups. Conflicts with commitments to treatment
facilities and/or other providers resulted in treatment dropout. Among those who
completed, satisfaction was reported as high. On average, women rated the change in
their knowledge and skills as "considerable" with mean ratings on the quality and
importance of MBRP-W between 3.4-3.5 where three is very good and four is excellent
(Amaro et al., 2014). Participants reported satisfaction with learning how to manage
feelings and meditating. There was a significant time-by-group interaction that was
observed for alcohol (p < .001) and drug severity (p < .05) with an average rate of
decline in addiction severity across dosages of MBRP-W. There was a greater rate of
decline in ASI scores for participants between baseline and 12-months if they attended
five to nine sessions (p < .05). Change in perceived stress over time varied significantly
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by exposure to MBRP-W with scores declining by an average of 1.7 points per 6-month
survey among all participants and high exposure groups experiencing an additional 2.3point decline (p <.05). The change in trauma scores did not vary significantly after
MBRP-W, however symptom scores among all participants declined by an average of 1.7
points at the 6-month survey interval (Amaro et al., 2014).
The pilot study by Witkiewitz, et al. (2014) compared the relative efficacy of
MBRP and RP in the prevention of substance use relapse during intensive residential
substance abuse treatment for women referred by the criminal justice system.
Hypotheses included that MBRP participants would report less drug use and fewer
drug-related consequences compared to those assigned to RP and that MBRP
participants would report fewer medical, legal, psychiatric, and family/social problems
compared to those assigned to RP. Recruitment of women referred to a nonprofit
women’s residential treatment center by the criminal justice system was conducted
between July 2010 and December 2011. One hundred and five participants (n = 105)
randomized into an MBRP (n = 55, mean age 35.8) and RP (n = 50, mean age 32.4). Of
these, 86 participants had mental health histories including having at least one suicide
attempt (46%), severe trauma (69.2%), chronic depression (70.7%), anxiety (73.5%),
and a history of abuse (89.2%). Substance use included “methamphetamine (35.5%),
heroin and other opiates (22.6%), cocaine (19.4%), alcohol (9.7%), marijuana (6.5%),
nicotine (3.2%), and other drugs (3.2%)” (Witkiewitz, et al., 2014, p. 537-538).
The 8-week intervention of twice weekly 50-minute sessions was an adapted
MBRP in rolling admission format. Primary objectives included teaching strategies to
assess high-risk situations for relapse, building cognitive and behavioral skills to cope
with craving and high-risk situations, and skills including goal-setting, drink refusal,
31

self-efficacy, social support, and a balanced lifestyle. Each MBRP session began with a
brief guided meditation, experiential exercises, followed by a discussion. Assigned 30minute exercises were practiced four days a week between sessions at scheduled times
(Witkiewitz, et al., 2014). The control group intervention was manual-based RP plus
portions of the Coping Skills Training Guide adapted to correspond with the MBRP
content. These interventions had the same structure, time commitment, group format,
and scheduling. Skill-building assignments were given to practice between sessions
approximating the time and effort of the MBRP group. Self-report measures included
the 30-day TLFB at baseline, 4-weeks, the end of the treatment program, and at the 15week follow up. The Short Inventory of Problems (SIP-M) was abbreviated from the
Inventory of Drug Use Consequences and collected at baseline and the 15-week followup. The subscales of the Addiction Severity Index (ASI) assessed the previous 30-days of
family/social, medial, and legal problems and psychiatric symptoms and was collected
at the baseline and 15-week follow-up. Focus was on individual subscales of the ASI
rather than the total scores to compare each dimension. Additional weekly assessments
were administered during the 8-weeks of treatment (Witkiewitz, et al., 2014).
Throughout the study period, 23 MBRP participants and 15 RP participants did not
receive or discontinued intervention and 27 (MBRP) and 24 (RP) were lost to follow-up.
Attrition analysis in the results did not reveal that missing data was associated with
demographic measures, primary or secondary outcomes, or treatment condition.
The data found that rates of drug use across the 15-week follow-up were low in
the sample with one participant in the MBRP group reporting 1 day of drug use and five
participants in RP reporting an average of 2.6 days (SD = 3.71) (Witkiewitz, et al., 2014).
MBRP participants had 96 percent fewer drug use days compared to RP (p = .001). Drug
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use consequences were found to be lower in the MBRP group (39%), although this result
was not statistically significant (p = .16). Furthermore, MBRP participants had
significantly lower scores on the legal status (p = .02) and medical status (p = .007)
subscales of ASI, however there were no significant differences on the family/social (p =
.87) or psychiatric status (p = .22) subscales. MBRP participants had lower scores on the
ASI total score but this difference was not significant in linear regression analyses (p
=.21). Data showed that the amount of mindfulness practice was not significantly
associated with primary or secondary outcomes at follow-up. Of the MBRP sample, 50
percent of participants reported “formal and informal practice at the end of treatment
and 30 percent reported continued practice at the 15-week follow-up. Of the 55
participants in the MBRP group, 27 reported an average of 2.7 days (SD = 1.8) of formal
meditation practice for an average of 19.6 minutes (SD = 16.5) per day at the end of
treatment” (Witkiewitz, et al., 2014, p. 540). In addition, 16 of those 55 women reported
an average of 2.8 days (SD = 1.62) of meditation for an average of 15.8 minutes (SD =
12.9) per day. Most participants reported at post-treatment that the SOBER space was
the most important skill learnt at post-treatment (Witkiewitz, et al., 2014).
A two-year study compared the “incremental efficacy and outcomes of MBRP to a
health education (HE) control for stimulant-dependent adults receiving contingency

management (CM)” (Glasner et al., 2017, p. 127). The hypotheses in this pilot trial were that MBRP wo
stimulant drug use relative to HE. Participants aged 22-67 years had a DSM-IV
diagnosis of stimulant dependence including some with diagnosed Generalized Anxiety
Disorders (GAD; 24%) or Major Depressive Disorder (MDD; 43%). Homelessness was
an exclusion factor unless recovery home placement arrangements were made. Drug use
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consisted of cocaine (49%) or methamphetamine (51%). Compensation was $20 for
weekly data collections visit and $30 for follow-up.
MBRP group sessions held weekly for 8-weeks featured a guided meditation,
homework review, and relapse prevention exercises guided by the MBRP manual.
Session modification from 120 minutes to 75 minutes enhanced engagement. A MS
therapist delivered the sessions after a 2-day manualized MBRP training seminar and
the seminar trainer supervised during initial phases of the trial. This intervention was
supplemented by a CM program that was delivered twice weekly featuring an initial
urine sample collection and a fishbowl method of drawing chips with values ranging
from motivational saying to cash vouchers between $5-$50. Compensation for chips was
dependent on missed or positive urine samples (Glasner et al., 2017). The control group
consisted of eight weekly Health Education (HE) sessions that incorporated a group
health psycho-education time equivalent to MBRP sessions. A media educational
program addressing various health and wellness topics plus CM was provided. Both
groups featured a 4-week CM lead-in plus 8-weeks of MBRP plus CM or HE plus CM
and 1-month follow up. (Glasner et al., 2017). The ASI was used to determine days of
stimulant use in the past 30 days and psychiatric and drug severity composite scores at
baseline, treatment-end, and follow-up. The Beck Depression Inventory (BDI-II) was
administered at the baseline, weekly during treatment, and follow-up. The Beck Anxiety
Inventory (BAI) was used to assess the severity of symptoms over the past week.
Mindfulness practice was evaluated using a weekly log of time spent using the provided
CD for at-home practice. The Difficulty in Emotion Regulation Scale (DERS) was used to
assess awareness, understanding, and acceptance of emotions and the White Bear
Suppression Inventory (WBSI) measured thought suppression or deliberate attempts to
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avoid unwanted thoughts. Weekly urine toxicology assays were used to determine the
presence of illicit stimulants; samples that were missing, refused, or invalid were
considered positives (Glasner et al., 2017). Assessment frequency varied with general
time points at the baseline, during treatment, and at the 1-month follow up. The 63
participants (n = 63) were divided into MBRP plus CM (n = 31) or HE plus CM (n = 32)
conditions. There were 23 participants who were terminated for a 2-week absence from
protocol participation, tampering with urine samples, or withdrawal. The MBRP group
reported practicing mindfulness an average of 18.5 days over the 8-week intervention
for a total of 145.3 minutes (Glasner et al., 2017).
The mean proportion of stimulant-free urine samples during the 8-week
intervention phase did not differ between groups (p > 0.05 with no group effect). In
mixed model analysis with stimulant use outcomes as a function of group, time, and
psychiatric diagnosis for those with MDD (after controlling for GAD, alcohol
dependence, and demographics) MBRP significantly decreased the likelihood of
stimulant use relative to HE (p = 0.03). Among the subgroup for GAD (controlling for
MDD, alcohol dependence, and demographics) MBRP effectively reduced the odds of
stimulant use significantly over time (p = 0.04) relative to HE. The ASI-drug severity
scores over time did not differ significantly as a function of group (p > 0.05). Depression
severity decreased significantly during and after treatment for those in MBRP relative to
HE with a significant group by time interaction (p = 0.04). Anxiety also decreased to a
greater extent over time for the MBRP group but the group by time interaction failed to
achieve significance, despite a larger effect size (Glasner et al., 2017, p. 131). Pairwise
contrasts showed an advantage on MBRP on anxiety severity at the 1-month follow up (p
= 0.01). The ASI psychiatric severity improved significantly over time in MBRP relative
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to HE (p = 0.04), however pairwise contrasts were significant only at 1-month follow up
(p = 0.01) but not at mid- or end-of-treatment. Analysis of changes in the FFMQ failed
to reveal a significant group by time interaction effect, but pairwise contrasts revealed
MBRP participants had significantly higher scores at mid-treatment (p = 0.01). A
difference was observed at treatment end, but the effect did not achieve significance (p =
0.09). The MBRP group had significantly lower scores (indicating less difficulty in
emotion regulation) at both treatment end (p = 0.02) and follow-up (p = 0.03). On the
WBSI, MBRP scores changed in the predicted direction but neither the group by time
interaction or any pairwise comparisons were significant (Glasner et al., 2017).
A non-randomized pilot study was conducted by Gryczynski et al. (2018) between
2015 and 2016 that used Transcendental Meditation (TM) to determine its success as a
relapse prevention strategy for AUD, including the feasibility and outcomes of the
intervention at 3-months post-discharge. Primary goals for the treatment intervention
were to assess the feasibility, acceptability, and uptake of TM during AUD treatment, to
compare of outcomes for patients who received TM training relative to TAU, and to
investigate the relationship between TM practice/adherence and outcomes. Participants
were male (65%) and female (35%) with a primary diagnosis of AUD and had plans to
stay in treatment for at least 2 weeks.
In addition to TAU, training from the standard TM curriculum was delivered on
the treatment site by certified instructors over four consecutive days in sessions lasting
approximately 1-hour each. After initial introductory and preparatory lectures and a
brief personal interview with the teacher, the instructor gave a personal mantra to each
participant and taught them the TM technique of sitting for 20 minutes with eyes closed
while repeating the mantra. It was recommended that participants continue practicing
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this technique twice daily. The next three sessions were in group format to verify
correctness and provide additional information including how to use TM daily. There
was a “10-day check” after the core course where participants were asked to attend
weekly “tune-up” trainings for 12-weeks post-discharge in local areas of the community.
The control intervention consisted of TAU with 3-4 weeks of residential services
including supervised withdrawal, structured activities, group and individual counseling
using CBT and 12-step approaches, relapse prevention, and integrated SUD/mental
health treatment. Follow up assessments were conducted 3-months after the treatment
period. There were 66 participants with a mean age of 43 who were recruited into TM (n
= 36) or TAU (n = 30) cohorts. Six participants in the TM group did not complete the
program due to moved discharge dates (n = 2) or withdrawal prior to or during training
(n = 4) (Gryczynski et al., 2018). Self-report data regarding alcohol use was gathered
using the TLFB method indicating the quantity, frequency, and amount of heavy
drinking (≥4 for females and ≥5 for males) and the amount of daily meditation was
assessed using the retrospective TLFB at the follow-up only. A TM experience
questionnaire evaluated perceived helpfulness for managing stress, craving, and alcohol
use at follow-up only. Additional self-report measures included the ASI-lite, PSS, the
Kessler-6 Psychological Distress Scale, the Alcohol Urge Questionnaire, and the Craving
Experience Questionnaire. There was an additional observational measure via
confidential face-to-face interviews with the participants (Gryczynski et al., 2018).
Follow-up rates at the 3-month time point were 80 percent for TAU and 87 percent for
TM.
Perceived helpfulness of TM was high throughout the 3-month follow-up with
participants reporting meditating 25 of the previous 30 days on average and most for
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more than 15 days. Perfect adherence, which involved twice daily meditation practice
every day in the previous 30 days, was practiced by 38 percent of the TM cohort.
Participants in both groups reported statistically significant reductions in stress on the
PSS (p < .001) with no differential effect for TM versus TAU. There were significant
reductions in craving reported on the Alcohol Urge (p < .001) and Craving Experience
Questionnaires (p < .001) with no significant differences between group measures. TM
(42 %) and TAU (54%) participants reported alcohol use in the 30 days preceding follow
up with no significant differences between the cohorts in the reduction of alcohol use (p
= .63) or days of heavy drinking (p = .83) from baseline to follow-up. Participants who
were closely adherent to TM practice (n = 16) had lower rates of past 90-day alcohol use
compared to the rest of the sample (p = .02). None of the closely adherent participants
returned to heavy drinking post-discharge compared to nearly half at 90 days postdischarge (p < .001) (Gryczynski et al., 2018). There was a statistically significant
advantage of TM adherence on return to heavy drinking (p < .01) and correlations
between the frequency of TM signifying better outcomes of relapse and drinking
behavior. These trends were not noted between twice daily meditation and changes in
stress on the PSS.
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DISCUSSION
Data analysis supports a wide range of improvements associated with
meditation-based interventions. Significant reductions in cravings and substance use
were demonstrated (Amaro et al., 2014; Bowen et al., 2009; Bowen et al., 2014; Davis et
al., 2018; Witkiewitz et al., 2014). Improvements in significant negative affect and stress
were also indicated (Amaro et al., 2014; Glasner et al., 2017). MBRP interventions had
greater long-term effects when compared to standard treatments (Bowen et al., 2014).
Consistency of meditative practice and continued support was found to be an important
factor related to long-term success (Gryczynski et al., 2018). Participation and attrition
were found to be limiting factors across the research presented.
The efficacy of MBRP as an alternative to 12-step or related aftercare programs
was found by Bowen et al. (2009) with significant improvements in substance use,
craving, awareness, and acceptance. A plateau at four months suggests diminished
benefits and returns to TAU levels possibly attributed to study design. Participants
returned to TAU groups and follow-up classes were not provided that could have
reinforced the changes produced by MBRP therapy. Bowen et al. (2014) provided
preliminary support for MBRP therapy in an ethnically diverse and challenging
population with high rates of homelessness and legal problems. Results showed that RP,
MBRP, and TAU may be equally effective at a 3-month follow up. Both RP and MBRP
favorably compared with TAU to lower the probability and severity of relapses at 6month follow up with RP delaying first time to drug use. MBRP may have a greater longterm effect. These findings appear conflicting despite both trials implementing the same
MBRP treatment parameters in the same treatment facility and both groups returning to
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TAU following the intervention (Bowen et al., 2009; Bowen et al., 2014). However, there
were potential differences in participation as 67.6 percent of MBRP participants
reported using skills taught in session at least once a week at the 12-month follow up in
2014 compared to 54 percent of MBRP participants continuing meditation practice at
the 4-month follow up in 2009. It is unclear in the 2014 study whether mandated
urinalysis testing was incorporated into 12-month follow-up assessments, which may
have resulted in more incentive to maintain abstinence. Given that the 2009 study was
limited by a 4-month follow-up it is uncertain whether the MBRP treatment affected
substance use or craving over after an extended lapse of time. Additional longitudinal
studies would be valuable in understanding this discrepancy.
Davis et al. (2018) found support for longevity of change related to treatment.
Both groups experienced similar decreases in craving during the treatment phase, but
MBRP scores remained lower in the post-treatment phase whereas the TAU group
showed immediate and substantial increases in craving after leaving the treatment
facility. Substance use following discharge increased relatively rapidly for the TAU
participants compared to a sustained low endorsement of substance use over the 6month follow-up period for those assigned to MBRP. MBRP participants had
significantly lower stress scores during both the treatment and post-treatment phase.
The enduring effects of an MBRP program may be explained by an improved
ability of MBRP participants to recognize and tolerate discomfort associated with
craving or negative affects (Bowen et al., 2014). Secondary analyses of Davis et al.
(2018) showed that MBRP assignment attenuated the associations between selfreported negative affect and craving, with craving significantly mediating AOD use at
follow-up. Only the TAU group showed a relationship between negative affect and post40

treatment substance use that was mediated by craving (Witkiewitz & Bowen, 2010). This
suggests that the MBRP group experienced reduced negative affect and craving resulting
in low rates of substance use whereas increased AOD use in the TAU cohort was
influenced by negative affect. A reduced severity of craving may be explained by
increases in the awareness of thoughts, sensations, and emotions accompanying
craving, and acceptance of non-reactivity to the craving response (Bowen et. al, 2009;
Davis et al., 2018). Repeated exposure to triggering stimuli with non-reactivity may
result in habituation to craving and decrease the intensity over time (Bowen et al.,
2009).
Glasner et al. (2017) demonstrated the efficacy of mindfulness for improving
symptoms of depression in MBRP participants relative to HE. There was an absence of
overall significant between-group differences in stimulant use. However, the MBRP
group demonstrated decreases in anxiety severity and those diagnosed with baseline
GAD or MDD were less likely to use stimulants over the course of treatment relative to
HE. This suggests that the use of mindfulness-based interventions for individuals with
addictions may be greatest for those with clinically significant negative affect. The
acquisition of coping skills emphasizing the acceptance of negative affect and discomfort
in MBRP may replace maladaptive self-medication behaviors (Glasner at al., 2017, p.
133).
Reductions in stress mediating the association between MBRP treatment
assignment and decreased substance use suggests that reducing ones stress can act as an
important mechanism in the recovery cycle (Amaro et al., 2014; Davis et al., 2018). This
was a significant finding when evaluating the efficacy of the MBRP-W intervention by
Amaro et al. (2014) which contributed to reductions in alcohol and drug addiction
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severity in a sample of culturally-diverse, low-income women, regardless of the modality
of SUD treatment in which women were enrolled, time in treatment, and engagement in
treatment at follow-up. Women tend to show higher scores on behavioral measures of
stress, indicating a gender difference in the stress response possibly due to higher rates
of trauma (Amaro et al., 2014). It is notable that all women in this sample reported a
history of exposure to traumatic events; understanding the prevalence of experiences
with trauma is a crucial element to refining SUD treatments. The study did not assess
history of a PTSD diagnosis, and changes in symptomatology may be more likely to
occur in those with a history of PTSD (Amaro et al., 2014). The study by Witkiewitz et al.
(2014) provided modest support for MBRP compared to RP in a sample of female
criminal offenders. MBRP participants reported significantly fewer legal and medical
problems at the 15-week follow-up, however relapse to any drug use was low in both
MBRP and RP compared to existing literature. This further supports that an MBRP
intervention may be effective in controlling the effects of substance use and improving
functioning in a population of females.
Measures of stress, craving, or alcohol use after integrating TM into an inpatient
AUD treatment showed no differences when compared to TAU (Gryczynski et al., 2018).
The TM intervention did not address relapse prevention factors outside of TAU and can
be considered less vigorous compared to the MBRP program. It is also possible that
providing participants with a “personal” mantra instead of allowing them to choose for
themselves may have resulted in difficulty connecting with the intimate experience
usually associated with a TM practice.
The feasibility and acceptability of a meditation-based program was
demonstrated across the studies. Good attendance and continued meditative practice
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was demonstrated with over half of participants continuing practice for at least 4months post-intervention, positive course ratings, and an absence of significant
differences in attrition rates between MBRP and TAU participants (Bowen et al., 2009).
Davis et al. (2018) successfully engaged participants in a traditionally challenging
younger population who showed comparable attrition rates to other SUD treatment
studies. There was evidence of skills acquisition in stimulant users who reported that
they practiced mindfulness between sessions and experienced mindfulness-specific
process changes in emotional regulation. This suggests that users had “the capacity to
learn and apply mindfulness skills and benefit from the emphasis on coping with
negative effect through acceptance, self-observation, and mindful awareness” (Glasner
et al., 2017, p. 133). The feasibility of integrating TM into an inpatient AUD treatment
experience was demonstrated in Gryczynski et al. (2018) as patients were willing to
enroll in the program and a large majority finished the core curriculum and follow-up
sessions. Most participants reported at 3-month follow-up that they were still
meditating regularly. The program completion rate in Amaro et al. (2014) was lower
than those found in previous MBRP studies (61% in Bowen et al., 2009 and 58% in Price
et al., 2012) as well as other intervention trials for SUD and mental health treatments,
however the study is unique in that most participants were engaged in residential
treatment programs with highly demanding schedules. The study by Witkiewitz et al.,
2014 supported that MBRP can be used during active treatment versus as an aftercare
program and participants may still use techniques after the treatment ends.
Studies that measured the relationship between participation and improvements
in substance use found that more involvement with meditative practice was correlated
with higher benefits. Better outcomes associated with MBRP-W was partially supported
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by greater reductions in alcohol and drug severity and perceived stress among those
women receiving the highest dosage of treatment. (Amaro et al., 2014). Greater
consistency of TM practice was associated with better outcomes as no participants that
had strong adherence returning to heavy drinking post-treatment. A potential theory is
that the practice of meditation produces better benefits for participants who are more
engaged. Alternatively, these participants may have been more motivated and would
have perhaps engaged in any additional intervention and were therefore possibly
predisposed to doing well (Gryczynski et al., 2018).
These outcomes support that adding mindfulness to a typical residential program
may better prepare participants for the relapse risks they face upon exiting (Davis et al.,
2018). The data suggests that continued mindfulness practice over time may strengthen
the ability to monitor and address factors contributing to well-being, thus supporting
long-term outcomes. Continued support following MBRP treatment may be necessary to
ensure to long-term success (Bowen et al, 2009; Bowen et al., 2014; Davis et al., 2018).
Mindfulness practice adapted into relapse prevention programs have shown to be
most efficacious for decreasing craving and stress and promoting longevity of abstinence
from substance use when compared to standard treatment programs. As a non
abstinence-based therapy that has shown to decrease rates of substance related
problems, MBRP and similar programs may provide an alternative treatment for
difficult SUD patients and/or those who lack a strong religious belief system. A potential
strength of the MBRP program when compared to other aftercare programs is that by
not insisting on abstinence it may provide benefits for people who are abusing
substances but are not ready to accept total abstinence.
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Program adherence and regular practice has been shown to be especially
important in abstinence success. Future programs could potentially benefit from
alterations that provide more regularly scheduled meditation classes after completion of
the initial therapy to promote regular practice and support in the community. Longer
and/or more intensive treatment programs may benefit particularly difficult persons
who frequently lapse to substance use. Additionally, programs could benefit from a
redesign to accommodate demanding schedules and facilitate participation including
follow-ups with those who miss treatments, provision of child-care services,
transportation if needed, and a focus on engagement strategies. Participation may be
improved by offering continuous groups or make up sessions for missed classes. Larger
studies with longer follow up periods are needed to determine accuracy in the longevity
of results and to further refine program designs as needed. With the pervasive
occurrence of SUDs and related health problems, it is imperative that nurses take an
active role in understanding successful treatments.
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LIMITATIONS
Several limitations were noted throughout the research. Brief follow-up periods
in some studies restricted the ability to examine effects of MBRP on long-term outcomes
(Amaro et al., 2014; Bowen et al, 2009; Glasner et al., 2017; Gryczynski et al., 2018;
Witkiewtiz et al., 2014). The retrospective self-report of substance use is potential
limitation, however TLFB is considered a reliable assessment of substance use and was
used in most of the studies (Bowen et al, 2009; Bowen et al, 2014; Davis et al., 2018;
Gryczynski et al., 2018; Witkiewitz et al, 2014). Additional biophysical measures such as
urine toxicology testing would strength the validity of substance use data (Amaro et al.,
2014; Bowen et al., 2009; Gryczynski et al., 2018; Witkiewitz et al, 2014). Attrition and
participation were significant limitations resulting in incomplete data during the follow
up period (Amaro et al., 2014; Bowen et al, 2009; Glasner et al., 2017; Witkiewitz et al.,
2014). Attrition may have confounded interpretation of drug use and other outcomes as
lost participants may have created a more homogenous, motivated, treatment-compliant
group for comparisons. Small sample sizes may have influenced the power to detect the
effects of interest and make statements regarding null growth (Davis et al., 2018;
Glasner et al., 2017; Gryczynski et al, 2018; Witkiewitz et al., 2014).
Study designs within treatment facilities provided ample opportunity for
participants to share feedback across conditions and completion of the training may
have been higher than it would be in an outpatient setting where intermittent
attendance and drop out may be more common (Davis et al, 2018; Gryczynski et al.,
2018; Witkiewitz et al., 2014). One facility allowed for control and intervention groups
to participate in separately scheduled mindfulness meditation sessions, which may have
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confounded results (Witkiewitz et al., 2014). The setting within a well-functioning
program and care continuum could be considered both a strength and weakness as this
may limit generalizability. Compensation was provided across all studies which may
have influenced attendance and motivation; however, studies that recorded independent
meditation practices showed high participant adherence (Bowen et al., 2009; Glasner et
al., 2017; Gryczynski et al., 2018; Witkiewitz et al., 2014). Other potential differences
between dosage groups were not measured in this study (such as motivation) which may
account for some findings (Amaro et al., 2014)
Additional limitations include participant exposure to other treatments
preventing detection of between-group differences (Gryczynski et al., 2018; Witkiewitz
et al., 2014). There were significant differences in the number of treatment hours
between MBRP and TAU (p <.001) in Bowen et al. (2009) which poses a potential study
limitation, and low rates of substance use in both groups limited variability and an
ability to find significant between-group differences. Davis et al. (2018) used a rolling
format with shorter MBRP sessions to include all aspects of the curriculum and several
modules which were abbreviated when compared to the original workbook. A potential
limitation was that one rater conducted the supervision of adherence and competence;
having multiple raters is beneficial to avoid bias in rater scoring and for validity checks.
Treatment status was concealed from research assistants conducting assessments and
procedures were established to maintain separation between staff delivering and
assessing the intervention, reflecting a strength of the study design (Davis et al., 2018).
In Glasner et al. (2017) no distinction was made between substance-induced depression
and/or anxiety versus substance-independent symptoms due to limitations of the
diagnostic instrument. Future studies should assess diagnoses more thoroughly to
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elucidate the features of drug users who could benefit most from these interventions.
Due to the court mandated programs in Witkiewitz et al. (2014) it was unethical to
include a no-treatment control group so it can only be concluded that both MBRP & RP
interventions caused lower relapse rates, with MBRP being slightly lower. The study
design by Amaro et al. (2014) did not include randomization or a control group creating
multiple threats to internal validity. Integrating satisfaction ratings and feedback
through the course of the intervention versus during the last session would have been
helpful by including data from people who did not attend. The small sample sizes of
White, Asian, and American Indian women prevented the inclusion of separate groups
in analysis, which is not ideal because is masks any unique characteristics and precludes
the identification of important racial disparities (Amaro et al., 2014).
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IMPLICATIONS

Nursing Practice
Nurses are exposed to the effects of substance abuse across a variety of healthcare
settings. Staying informed on the most current and effective treatments is necessary to
help patients organize a successful plan of care. In locations where they can accept more
responsibility, interested nurses can seek out the appropriate training to teach
meditation to people with SUDs to help manage their substance use and relapse risks.
Understanding the issues of abuse and effective treatments can provide confidence for
healthcare workers to approach a situation where someone is struggling with an SUD.

Education
Research supports the use of meditation for improving psychological and
physical symptoms related to negative affect and people with SUDs. Nursing education
on available treatment programs, meditation styles, and associated benefits is important
for providing community interventions. This may encourage greater user participation
through the nurse’s understanding of the importance of support and self-management.

Research
More research is needed to address additional factors related to substance use
such as trauma and social disconnection and how this influences negative coping
strategies in the community. This understanding can be incorporated into future
meditation and RP training research. Future longitudinal studies would be beneficial to
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determine the strength of enduring effects. Program refinements based on additional
research may address issues of adherence and community support to promote regular
practice. Nurses have important psychosocial roles in establishing therapeutic
relationships with patients. Taking an active role in meditation research can help nurses
provide better care by understanding how incorporating these treatments can reduce
negative affect and improve the quality of life in people with SUDs.

Policy
Currently, there is no universal standard of treatment for people with SUDs. As
research that explores the root of addiction progresses and effective treatment
approaches becomes refined it is important that a standard protocol is created and
implemented for people across a range of socioeconomic backgrounds. Currently, there
is little attention and funding given issues of mental health and substance abuse in
America despite the impacts seen across many facets of society. Knowledge of SUD
research addressing meditation-based interventions can help advance policy changes by
legislation providing greater availability and more research in treatment centers across
the country.

50

51

APPENDIX A: Review of Methodology
Review of EBSCOhost database including CINAHL, CINAHL Plus with Full Text, Cochrane Central
Register of Controlled Trials, MEDLINE, PsycARTICLES, and psycINFO with publications between
2008-2019 using special limiters (MH "Substance Abuse") OR (MH "Substance Abusers") OR
addict* OR "drug abuse*" or "substance abuse*" or "alcohol abuse*" or "narcotic abuse*" or "narcotic
use*" or "drug use*" or "alcohol use*" or "drug addict*" or "substance addict*" or "substance use
disorder*" or SUD* or "substance use*" or "drug dependence" or "alcohol dependence" or "narcotic
dependence" or "substance dependence" or "alcohol*" or "dipsomania*" or "chemical abuse*" or
"solvent abuse*" AND relapse or recur* or regress* AND meditat* or mindful* or "mindfulness based
stress reduction" or MBSR or "mindfulness based relapse prevention" or MBRP or "mindfulness
based therapeutic communit*" or MBTC.
n = 234

→

INITIAL REVIEW:

Removal of irrelevant articles = 144
n = 90

→
Removal of non-English articles = 5
n = 85

→
Removal for use of spiritual practice,
pharmacological intervention, or
movement-based therapy = 4
n = 81

→
Removal of repeat articles = 8
n = 73

→
Removal of systemic reviews and editorials = 33
n = 40
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→
→

Removal of qualitative research = 2
n = 38

→
Removal for inclusion of comorbid disorders
(other than affective disorders) = 2
n = 36

DETAILED REVIEW:

→
Removal for not addressing relapse
prevention = 11
n = 25

→
Removal for use of massage therapy = 1
n = 24

→
Removal of secondary analyses, short
communications, and study protocols = 10
n = 14

→
Removal of weak articles (group size <20, no
control group, weak design) = 4
n = 10

→
Removal of articles addressing nicotine
smokers = 3
n=7

TOTAL NUMBER OF ARTICLES IN FINAL EDITS
n=7
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APPENDIX B: Table of Outcomes
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Authors,
Year,
Country

Purpose

Study
Design

Intervention

Measures

Sample

Outcomes

Amaro,
Spear,
Vallejo,
Conron, &
Black.
(2014).
USA.

To assess the
feasibility and
acceptability
for integrating
an MBRP-W
program into
SUD treatment
for culturally
diverse, lowincome
women.

Single
group
repeated
measures
design

Independent
Variable:
MBRP-W adapted
from MBRP to
address women with
a history of trauma
exposure.

Self Report:
FEASIBILITY &
ACCEPTABILITY: Attendance
sheets & satisfaction
questionnaires

Amount:
N = 318

1. There was a
100% history of
trauma exposure
and 92% with
recent exposure.

TREATMENT DOSAGE: To
compare the effects of lower (14) and higher (5-9) sessions
doses compared to none.

Gender: Female

Length:
April 2003December
2006 plus
12-month
follow-up.
IRB: YES

Control: NONE
Length: 9 weeks
plus 12-month
follow-up.

ALCOHOL & DRUG
ADDICTION SEVERITY: The
alcohol and drug measures
from the ASI evaluating the
previous 30 days of use.
PERCEIVED STRESS: The PSS
to assess response to stressors
during the previous 30 days.
POST-TRAUMATIC STRESS
SYMTPOMALOGY: An
adapted version of the
Posttraumatic Diagnostic
Symptom Scale (PDS).
TRAUMA EXPOSURE: Life
Stressor Checklist to assess
lifetime and current exposure
to traumatic or stressful events.
Frequency:
1. Baseline interviews
2. 6-month follow-up
3. 12-month follow up
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Age: 18-58
(34 M)

Characteristics:
-45.3%
Hispanic, 34.6%
non-Hispanic
Black, 20.1%
Non-Hispanic
White and other.
-2.2% employed
-7.6% had been
arrested in the
previous 30
days.
-45.6% were
court-mandated
for treatment.
-From
residential
(73.9%) and
outpatient
(26.1%)
facilities.
Compensation:
$20 at baseline
& $40/ followup interviews.

2. Session Dosage:
5-9 sessions: 35.8%
1-4 sessions: 19.8%
No sessions: 44.3%
3. Scheduling
conflicts with
treatment facilities
and/or other
providers
prevented
consistent
participation.
4. Satisfaction was
reported high.
5. There was an
average decline in
addiction severity
across all dosages
of MBRP-W.
6. Alcohol and drug
severity and
perceived stress
decreased across
all groups with
greater reductions
in the highest
dosage groups.

7. Change in
trauma scores did
not vary
significantly with
MBRP-W as
symptom scores
among all
participants
declined.
Bowen,
Chawla,
Collins,
Witkiewitz,
Hsu, Grow,
Clifasefi,
Garner,
Douglass,
Larimer, &
Marlatt,
(2009).
USA.

To evaluate
MBRP in
comparison to
TAU on SUDs.

Pilot RCT
Length: 8
weeks of
treatment
plus 4month
follow up
period.
IRB
Approval:
YES

Independent
Variable: MBRP
Control: TAU per
standard outpatient
aftercare of
treatment agency.
Length: 8 weeks
plus 4-month follow
up period.

Self Report:
SUBSTANCE USE:
The Timeline Followback
(TLFB) assessing daily use 60
days prior to treatment
admission/assessment.
ALCOHOL & DRUG
CRAVING:
Penn Alcohol Craving Scale
(PACS) adapted to include drug
craving.
ALCOHOL & DRUG USE
CONSEQUENCES:
Short Inventory of Problems
(SIP-AD) assessing impulse
control, social responsibility, &
physical, interpersonal, &
intrapersonal consequences.
MINDFULNESS:
The Five Factor Mindfulness
Questionnaire (FFMQ)
ACCEPTANCE: The
Acceptance and Action
Questionare (AAQ) assessing
acceptance vs avoidance &
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Amount:
N = 168
4-months post
intervention:
n = 43
Age: 18-70
(40.5 M)
Gender:
M: 63.7%
F: 36.3%
Characteristics:
-Caucasian
(51.8%), African
American
(28.6%),
Multiracial
(15.3%), Native
American (7.7%)
-Legally
mandated
(57%+2%)
-Homeless (75%
+ 19%)
Compensation:
$45 gift card at

% Participation:
MBRP:
-Attended 65% of
sessions
-86% practiced
meditation postintervention
-54% continued at
4-months postintervention
1. AOD use
decreased to
greater extent
compared to TAU:
-MBRP had 86%
(M) decrease in
AOD use x 2
months
-MBRP: 2.1 (M)
days of use
-TAU: 5.4 (M)
days of use
2. No significant
effects of MBRP on
substance use
problems.

control of negative experiences.
MEDITATION PRACTICE:
Weekly recording of type & #
minutes of practice.

baseline & postassessments,
$50 gift
card/additional
assessment

Frequency:
1. Baseline
2. Immediately postintervention
3. 2-months post-intervention
4. 4-months post-intervention.

3. PACS craving
model was
significant
(p<.001): Craving
decreased more in
MBRP possibly
from an increase in
awareness of
craving &
acceptance of/nonreactivity to the
craving response.
4. Acceptance &
acting with
awareness
increased in
MBRP; decreased
in TAU.
5. Plateaus of all
treatment effects at
4-months postintervention
suggests gains were
returning to TAU
levels (possibly due
to study design).
6. MBRP course
was rated highly
important with
high likelihood of
continuing
practices.

Bowen,
Witkiewitz,
Clifasefi,
Grow,

To assess the
relative
efficacy of
MBRP, RP,

RCT.
Length:
October

Independent
Variable:
Weekly MBRP in 2H
small group sessions

Self Report:
ABSTINENCE: The Addiction
Severity Index at baseline and
end of treatment.
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Amount:
N = 286
MBRP: 103
RP: 88

% Participation
(use of skills at 12month follow up):
MBRP: 67.6%

Chawla,
Hsu,
Carroll,
Harrop,
Collins,
Lustyk, &
Larimer
(2014).
USA.

and TAU on
12-month SUD
outcomes

2009 – July
2012

(n=6-8) per MBRP
treatment manual.

IRB
Approval:
YES

RP: Matched MBRP
in time, format, size,
location and scope
of assigned
homework.
*Both RP & MBRP
groups were
removed from
primary aftercare
groups & returned
after program
completion.
Control:
Abstinence-based
TAU primarily
processed oriented
based on
Alcoholics/Narcotics
Anonymous in
groups (n=95) for
1.5 H weekly.

DEPENDENCE:
The Severity of Dependence
Scale (SDS).
SUBSTANCE USE:
The Timeline Follow-back
accounting for 30 days before
baseline and periods between
assessments.
Biophysical:
1. URINALYSIS DRUG &
ALCOHOL SCREENING: From
subset of participants (n=199)
court mandated or otherwise
indicated for testing.
Frequency:
1. Baseline
2. 3-months post-intervention
3. 6-months post-intervention
4. 12-months post-intervention

Length: 8 weeks of
MBRP or RP with
12-month follow up
period.

TAU: 95
At 12-months:
MBRP: n = 83
RP: n = 72
TAU: n = 76
*Participants
with missing
data at 12month follow up
were
significantly
older.
Age: 18-70
Gender:
Male (71.5%)
Female (28.5%)
Characteristics:
-White (57.9%),
ethnic/racial
minority (42.1%)
-Completed
initial intensive
inpatient or
outpatient care.
Compensation:
$40 gift
cards/completed
assessment +
$40 bonus for
completion of all
assessments +
$20-$30
attendance
bonuses.
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RP: 100%
1. In all groups the
rates of substance
use and heavy
drinking were
much lower than
other SUD studies.
2.
MBRP & RP groups
vs. TAU:
-54% decreased
risk of relapse to
drug use
-59% decreased
risk of relapse to
heavy drinking.
3. MBRP had a 21%
increase in relapse
risk to first drug
use vs. RP; groups
did not
significantly differ
on time to first
heavy drinking day.
4. 3-month followup:
-No significant
group differences
on drug or alcohol
use days between
all groups.
5. 6-month followup:
-RP and MBRP
groups had 31%
fewer days of

drinking vs. TAU.
-No significant
differences
between MBRP
and RP.
6. 12-month followup: MBRP
participants
reported 31% fewer
drug use days
7. Continued
mindfulness
practice may
strengthen the
ability to address
factors in wellbeing, supporting
long-term
outcomes.
Davis,
Berry,
Dumas,
Ritter,
Smith,
Menard, &
Roberts
(2018).
USA.

To compare
TAU plus
MBRP against
TAU plus
additional 12step meetings
on perceived
stress, craving,
and substance
use.

RCT in
rolling
group
format.
Length:
September
2015November
2016
IRB
Approval:
YES

Independent
Variable: 8 x 1.5H
group sessions (n =
3-12) of MBRP x 2
weekly d/t average
residential stay of
one month to ensure
course completion.
Groups were held in
rolling format.
Control: TAU
provided by the
residential facility
including cognitive
behavioral
treatments and 12step approaches

Self Report:
SUBSTANCE USE:
The TLFB for the previous 2
weeks PLUS the Substance
Frequency Scale (SFS) to
measure the days of problems
associated with substance use.
CRAVING:
The GAIN assessment
instrument corresponding to
the new DSM-IV criteria for
craving.
STRESS:
The Perceived Stress Scale.
Biophysical:
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Amount:
N = 79
MBRP: 44
TAU: 35
At 5-months:
n = 38
Age: 18-29
(25.3 M)
Gender:
Male (65%)
Female (35%)
Characteristics:
-White (91%)
-Majority had 1+
parent with a

% Participation:
Between 93.3100% (95.6% M)
attendance in all 8
MBRP sessions.
1. At the end of
treatment TAU
showed immediate
increases in
substance use
(p<.001) that
peaked & plateaued
around 13 weeks
after treatment.
2. MBRP abstained
from substance use

plus attendance in
up to 8 extra
support groups.
Length: 8 weeks
with 6-month follow
up period.

1. URINALYSIS: Utilized
during treatment phase; 85%
of participants lived outside the
study area so urinalysis was not
possible during post-treatment
phase.
Frequency:
1. Treatment phase:
-Baseline
-2 weeks
-1 month
2. Post treatment phase:
Biweekly for 6-months (12
occasions)

SUD and were
unemployed.
-Most spent
significant time
in jail/prison
-90% were
polysubstance
abusers.
Compensation:
$10 /assessment
completed ($150
maximum) + 2
$150 bonus
drawings during
follow up period.

immediately after
treatment and
maintained a flat
trajectory through
the study (p=.76).
3. Nearly identical
declines in craving
during the
treatment phase
which diverged
after leaving
(p<.001) with
MBRP maintaining
low levels (p=.29)
& TAU showing
immediate
increases with
plateaus 14 weeks
post-treatment
(p<.001).
4. Only MBRP
showed significant
improvements in
stress levels during
treatment phase
(p=.18) and tended
to maintain lower,
treatment-acquired
stress levels
through the study
(28 weeks posttreatment).
5. TAU showed
immediate rises in
stress levels which
gradually slowed
(p=.03) &
plateaued 17 weeks
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post-treatment.
6. Post-treatment
substance use
decreased for
individuals
assigned to MBRP
via decreases in
perceived stress.
7. Adding
mindfulness to
residential
treatment
programs may help
better prepare
young adults for
environmental
relapse risks they
face after exiting
8. Reducing ones
stress is an
important
mechanism in the
recovery cycle.
Glasner,
Mooney,
Ang,
Garneau,
Hartwell,
Brecht, &
Rawson
(2017).
USA.

To compare
efficacy and
outcomes of
MBRP to a HE
control for
stimulantdependent
adults
receiving CM.

A pilot RCT
Length: 2
years.
IRB: YES

Independent
Variable:
Group MBRP
sessions weekly over
8 weeks with
modifications of
sessions from 120 to
75 minutes in
addition to CM
delivered twice
weekly.

Self Report:
STIMULANT USE: The
Addiction Severity Index (ASI)
to determine past 30 days of
stimulant use and psychiatric &
drug severity composite scores
at baseline, treatment-end, and
follow-up.

Amount:
N = 63
MBRP+CM: 31
HE+CM: 32
n = 40

DEPRESSION: The Beck
Depression Inventory (BDI)-II
at baseline, weekly during
treatment, and follow-up.

Characteristics:
-Some GAD
(24%) or MDD
(43%).
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Age: 22-67
(45.3 M)

% Participation:
MBRP: practiced
mindfulness ~18.5
days during
intervention (145.3
mins).
1. Both groups had
the same amount
of stimulant-free
samples (p>0.05
with no group
effect) and ASI-

Control:
8 weekly
HE sessions of
manualized, group
health
psychoeducation of
equivalent duration
to MBRP plus CM.
Length: 4-week CM
lead-in plus 8-weeks
of MBRP+CM or
HE+CM and 1month follow up.

ANXIETY: The Beck Anxiety
Inventory (BAI) to assess
severity over past week.
MINDFULNESS PRACTICE:
Weekly log of minutes.
EMOTION REGULATION: The
Difficulty in Emotion
Regulation Scale (DERS) to
assess awareness,
understanding, and acceptance
of emotions.
THOUGHT SUPPRESSION:
The White Bear Suppression
Inventory (WBSI) to measure
thought suppression or
deliberate attempts to avoid
unwanted thoughts.
Biophysical:
1. URINE TOXICOLOGY
ASSAYS: Weekly to determine
the presence of stimulant
metabolites.

Compensation:
$20/weekly data
collections visit
+ $30 for followup.

drug severity
scores (p>0.05).
2. In mixed model
analysis MBRP
significantly
decreased the
likelihood of
stimulant use
relative to HE
(p=0.03).
3. Among those
with GAD MBRP
reduced the odds of
stimulant use
significantly over
time (p=0.04).
4. Depression
severity decreased
during/after
treatment in MBRP
with a significant
group x time
interaction
(p=0.04).
5. Pairwise
contrasts showed
an advantage on
MBRP on anxiety
severity at 1-month
follow up (p=0.01).
6 The ASI
psychiatric severity
improved
significantly over
time in MBRP
(p=0.04). Pairwise
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contrasts were
significant only at
1-month follow up
(p=0.01).
7. MBRP indicated
less difficulty in
emotion regulation
at treatment end
(p=0.02) and
follow-up
(p=0.03).
8. Evidence of
skills acquisition as
participants
practiced
mindfulness
between sessions
and showed
mindfulnessspecific process
changes.
Gryczynski,
Schwartz,
Fishman,
Nordeck,
Grant,
Nidich,
Rothenberg,
& O’Grady.
(2018).
USA.

To determine if
TM holds
promise as a
relapse
prevention
strategy for
AUD.

Nonrandomized
pilot study.
Length:
2015-2016
IRB: YES

Independent
Variable:
Training from the
TM training
curriculum at the
treatment site over 4
consecutive 1H
sessions + “10-day
check” after the core
course & weekly
“tune-up” trainings
for 12-weeks postdischarge in the
community. This
was in addition to
TAU.

Self Report:
ALCOHOL USE: TLFB
TM PRACTICE
QUESTIONNAIRE: Amount of
daily meditation via
retrospective TLFB at followup only.
TM EXPERIENCE
QUESTIONNAIRE: Evaluating
perceived helpfulness for
managing stress, craving, and
alcohol use at follow-up only.

Amount:
N = 66
TM: 36
TAU: 30
At 3-months:
TM: n = 26
TAU: n = 24
Age: 43 (M)
Gender:
65% male
35% female
Characteristics:
-Completed
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1. Perceived
helpfulness was
high over 3-month
follow-up with
participants
reporting
meditating
regularly:
-38% had perfect
adherence of 2x
daily meditation in
past 30 days.
2. Both groups
reported
statistically

Control:
TAU as provided by
the facility including
3-4 weeks of
residential
treatment (group
and individual
counseling using
cognitive-behavioral
and 12-step
approaches).
Length: 4 days of
core treatment plus
10-day check and
weekly tune-ups 12weeks post
discharge and 3month follow up.

ADDICTION SEVERITY
INDEX-LITE
PERCIEVED STRESS SCALE
KESSLER-6
PSYCHOLOGICAL DISTRESS
SCALE
ALCOHOL URGE
QUESTIONNAIRE
CRAVING EXPERIENCE
QUESTIONNAIRE
Observational: Confidential
face-to-face interview
Frequency:
1. Baseline
2. 3-months post-discharge

medically
assisted
withdrawal with
plans to stay in
treatment for at
least 2 weeks.
Compensation:
$30/baseline +
$40/follow-up
assessments.

significant
reductions in stress
(p<.001) with no
differential effect
for TM versus TAU.
3. Participants
reported significant
reductions in
craving (p<.001)
and Craving
Experience
(p<.001) with no
significant
differences
between groups.
4. 42% of TM and
54% TAU reported
alcohol use in the
30 days before
follow-up with no
significant
differences
between groups in
alcohol use (p=.63)
or days of heavy
drinking (p=.83)
from baseline to
follow-up.
5. Participants who
were closely
adherent to
practice (n=16) had
lower rates of
alcohol use
compared to the
rest of the sample
(p=.02). None of
the closely
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adherent
participants
returned to heavy
drinking postdischarge.
6. There were
correlations
between the
frequency of TM
practice correlating
with better
outcomes of
relapse and
drinking behavior.
Witkiewitz,
Warner,
Sully,
Barricks,
Stauffer,
Thompson,
& Luoma.
(2014).
USA.

To compare
MBRP and RP
in the
prevention of
substance use
relapse for
women
referred by the
criminal justice
system.

A pilot RCT.
Length:
Recruitment
between
July 2010December
2011 plus
15-week
follow up
period.
IRB: YES

Independent
Variable:
Adapted MBRP in
rolling admission so
participants began
treatment when they
were ready with 2x
weekly 50-minute
sessions over 8
weeks.
Control: RP plus
portions of the CST
Guide adapted to
correspond with
MBRP content,
structure, group
format, and
scheduling.
Length: 8-week
intervention + 15week follow-up.

Self Report:
ALCOHOL/DRUG USE: 30day TLFB.
SUBSTANCE USE
CONSEQUENCES: The Short
Inventory of Problems (SIP-M)
abbreviated from the Inventory
of Drug Use Consequences at
baseline and 15-week followup.
FAMILY/SOCIAL, MEDICAL,
& LEGAL PROBLEMS,
PSYCHIATRIC SYMPTOMS:
Subscales of the ASI assessing
the previous 30 days at
baseline and 15-week followup.
WEEKLY ASSESSMENTS:
During 8-weeks of treatment.
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Amount:
N = 105
MBRP: 55
RP: 50
At 15-weeks:
MBRP: n = 5
RP: n = 11
Age:
MBRP: 35.8 M
RP: 32.4 M
Gender: Female
Characteristics:
-Referred to
women’s
residential
treatment by the
criminal justice
system (e.g. for
drug
use/possession,
burglary,

1. Formal and
informal practice:
50% at end of
treatment
30% at 15-week
follow-up.
2. The majority of
participants report
that the SOBER
space was the most
important skill
learnt.
3. Amount of
mindfulness
practice was not
significantly
associated with
primary or
secondary
outcomes.
4. Rates of drug use

Frequency:
1. Baseline: In last week of
stabilization & detoxification.
2. Mid-treatment: 4-weeks
follow start.
3. Post-treatment: At the end of
the treatment program.
4. 15-week follow-up

prostitution)
-n = 86 had
mental health
histories: 1+
suicide attempt
(46%), severe
trauma (69.2%),
chronic
depression
(70.7%), anxiety
(73.5%), and
history of abuse
(89.2%).
Compensation:
Gift cards:
Baseline: $10
Mid-: $5
Post-: $10
Follow up: $30.

were low with 1
MBRP reporting 1
day of drug use & 5
RP reporting ~2.6
days (SD=3.71) of
drug use.
5. MBRP
participants had
96% fewer drug use
days compared to
RP (p=.001).
6. Drug use
consequences were
39% lower in the
MBRP group; this
result was not
statistically
significant (p=.16).
7. MBRP had
significantly lower
scores on the legal
(p=.02) and
medical status
(p=.007) subscales
of ASI.
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